John T. Cavan
2012
In 2012, John T. Cavan earned a total compensation of $364.5K as Chief Accounting Officer at Stemline Therapeutics.
Compensation breakdown
| Bonus | $40,000 |
|---|---|
| Option Awards | $287,038 |
| Salary | $37,500 |
| Total | $364,538 |
Cavan received $287K in option awards, accounting for 79% of the total pay in 2012.
Cavan also received $40K in bonus and $37.5K in salary.
Rankings
In 2012, John T. Cavan's compensation ranked 9,640th out of 11,487 executives tracked by ExecPay. In other words, Cavan earned more than 16.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,640 out of 11,487 | 16th |
Division Manufacturing | 3,569 out of 4,253 | 16th |
Major group Chemicals And Allied Products | 982 out of 1,198 | 18th |
Industry group Drugs | 738 out of 920 | 20th |
Industry Pharmaceutical Preparations | 570 out of 700 | 19th |
Source: SEC filing on April 30, 2013.
Cavan's colleagues
We found four more compensation records of executives who worked with John T. Cavan at Stemline Therapeutics in 2012.